ADAM8 Is an Antigen of Tyrosine Kinase Inhibitor-Resistant Chronic Myeloid Leukemia Cells Identified by Patient-Derived Induced Pluripotent Stem Cells

Properties of cancer stem cells involved in drug resistance and relapse have significant effects on clinical outcome. Although tyrosine kinase inhibitors (TKIs) have dramatically improved survival of patients with chronic myeloid leukemia (CML), TKIs have not fully cured CML due to TKI-resistant CML...

全面介紹

Na minha lista:
書目詳細資料
發表在:Stem Cell Reports
Main Authors: Miyauchi, Masashi, Koya, Junji, Arai, Shunya, Yamazaki, Sho, Honda, Akira, Kataoka, Keisuke, Yoshimi, Akihide, Taoka, Kazuki, Kumano, Keiki, Kurokawa, Mineo
格式: Artigo
語言:Inglês
出版: Elsevier 2018
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5919294/
https://ncbi.nlm.nih.gov/pubmed/29429960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.stemcr.2018.01.015
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍